Quarterly report pursuant to Section 13 or 15(d)

Stockholders' equity

v3.23.3
Stockholders' equity
 9 Months Ended
Sep. 30, 2023
Stockholders' equity  
Stockholders' equity

​

Note 13 — Stockholders’ equity

On August 10, 2020 the Company entered into a sales agreement with Cowen and Company, LLC (“Cowen”) (the “Sales Agreement”) under which we may from time to time issue and sell American Depositary Shares (“ADSs”) representing our ordinary shares through Cowen in at-the-market (“ATM”) offerings for an aggregate offering price of up to $200 million. As of September 30, 2023, $197,360,000 remained available for sale under the Sales Agreement.

On April 8, 2022 the Company entered into a new sales agreement with Cowen (the “2022 Sales Agreement”) under which we may from time to time issue and sell ADSs representing our ordinary shares through Cowen in ATM offerings for an aggregate offering price of up to $200 million. In the nine months ended 30 September, 2023 the Company sold 642,416 ADSs under the agreement representing 3,854,496 ordinary shares resulting in net proceeds to the Company of $596,716 after deducting commissions payable under the 2022 Sales Agreement and estimated issuance costs. As of September 30, 2023, approximately $186,067,867 remained available for sale under the 2022 Sales Agreement.

​

​